Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Sumitomo Dainippon Pharma Co Ltd (4506)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
390.0 -5.0    -1.27%
19/04 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3495000006 
  • Volume: 2,043,500
  • Bid/Ask: 388.0 / 390.0
  • Day's Range: 389.0 - 399.0
Sumitomo Dainippon Pharma 390.0 -5.0 -1.27%

4506 Balance Sheet

 
Featured here, the Balance Sheet for Sumitomo Dainippon Pharma Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 264167 292746 320798 381860
Cash and Short Term Investments 36457 60397 100737 163652
Cash - - - -
Cash & Equivalents 36457 60397 94475 143478
Short Term Investments - - 6262 20174
Total Receivables, Net 97306 96887 98670 98630
Accounts Receivables - Trade, Net 94465 93892 95774 95908
Total Inventory 104769 107610 101482 94405
Prepaid Expenses - - - -
Other Current Assets, Total 25635 27852 19909 25173
Total Assets 1059970 1148855 1140702 1134742
Property/Plant/Equipment, Total - Net 59019 60202 60050 58909
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 222415 234568 227371 209415
Intangibles, Net 332372 356580 350985 329314
Long Term Investments - - 170598 144399
Note Receivable - Long Term 2841 2995 2896 2722
Other Long Term Assets, Total 173195 195306 170598 144399
Other Assets, Total 41900 48028 39883 51967
Total Current Liabilities 421155 370747 363618 370888
Accounts Payable 50385 57712 46329 52141
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt 227588 - 127617 90588
Current Port. of LT Debt/Capital Leases 227588 139588 127617 4660
Other Current liabilities, Total 143182 173447 189672 223499
Total Liabilities 716377 736810 723679 727960
Total Long Term Debt 184254 244212 244170 251124
Long Term Debt 184254 244212 244170 244128
Capital Lease Obligations - - - 6996
Deferred Income Tax 48832 56808 49129 36505
Minority Interest 42 38 36 33
Other Liabilities, Total -380970 65005 -276367 -236654
Total Equity 343593 412045 417023 406782
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 22400 22400 22400 22400
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 171708 217421 246293 280999
Treasury Stock - Common -682 -682 -682 -682
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 150167 172906 149012 104065
Total Liabilities & Shareholders' Equity 1059970 1148855 1140702 1134742
Total Common Shares Outstanding 397.29 397.29 397.29 397.29
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4506 Comments

Write your thoughts about Sumitomo Dainippon Pharma Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email